ZAHID MAHMOOD: Open Payments
NPI 1740805464 · CARO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 18 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $93 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $78 |
| Neurocrine BioSciences, Inc. | 4 | $71 |
| Philips North America LLC | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: INGREZZA, OTEZLA, Vest Therapy Und, INSPIRE, REXULTI, FANAPT, CREXONT, NURTEC ODT.
Industry payments across MI — which companies pay providers there.
